Big Data is our greatest potential weapon in the fight against cancer. Despite countless advancements, cancer remains the second leading cause of death worldwide, and the burden on patients, families and society is profound. Advanced diagnostics for cancer represent a major market opportunity for life sciences companies. There is increasing demand for noninvasive, diagnostic assays that can detect cancers earlier; molecularly subtype tumors to guide therapy decisions; and monitor cancer recurrence intreated individuals.
Three pressing needs in cancer diagnostics loom large: The first is earlier stage identification, identifying cancer before it has spread to other parts of body.
Continue reading this report plus more!
Monthly Access $9.99
Single Paper $59.99